Condylox
NDC Package 63094-0101-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Condylox is a medication used on the skin to treat external genital warts. Marketed by Dpt Laboratories, Ltd., this product is identified by NDC 63094-0101 and is authorized under FDA application NDA019795.

Identification & Billing

NDC Package Code
63094-0101-1
Package Description
1 BOTTLE, GLASS in 1 CARTON / 3.5 mL in 1 BOTTLE, GLASS
Product Code
63094-0101
11-Digit Billing Format
63094010101

Clinical Specifications

Proprietary Name
Condylox
Dosage Form
-
Usage Information
This medication is used on the skin to treat external genital warts.

Regulatory & Marketing

Labeler Name
Dpt Laboratories, Ltd.
FDA Application #
NDA019795
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-22-1997
End Marketing Date
09-30-2009
Listing Expiration
09-30-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63094-0101-1 identifies a specific commercial package of 1 bottle, glass in 1 carton / 3.5 ml in 1 bottle, glass of Condylox, labeled by Dpt Laboratories, Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dpt Laboratories, Ltd. on May 22, 1997. The current certification is valid through September 30, 2009.

What are the primary indications for this medication?

This medication is used on the skin to treat external genital warts.

How is this Dpt Laboratories, Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63094010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
63094-0101-1
11-Digit CMS (5-4-2)
63094-0101-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.